OraSure Technologies Prepares for Earnings Call
OraSure Technologies, Inc. (NASDAQ: OSUR) has announced its upcoming earnings conference call to discuss the financial results for the fourth quarter of 2024, scheduled for 5 p.m. ET on February 25, 2025. This call is a significant opportunity for investors and stakeholders to glean insights into the company’s performance and strategic direction.
Details of the Conference Call
Listeners can participate in the live conference call by accessing the webcast on OraSure's investor relations webpage. It's important for attendees to log in at least 10 minutes before the start of the call to ensure they can register without issues. After the call concludes, the recording will be available for approximately 90 days, allowing those who couldn’t attend live to catch up on the essential details.
How to Ask Questions
For those interested in engaging during the call, OraSure encourages participants to pre-register via the provided link. This process facilitates a smooth experience, ensuring that questions can be asked efficiently, allowing for meaningful dialogue.
About OraSure Technologies, Inc.
OraSure is dedicated to transforming healthcare by providing actionable insights and innovative solutions that connect individuals to healthcare services seamlessly. Their commitment to improving access and enhancing the quality of care is evident through their development of easy-to-use testing and sample management products.
Innovations in Health Solutions
As a leader in the medical diagnostics space, OraSure, along with its subsidiaries DNA Genotek Inc. and Sherlock Biosciences, Inc., specializes in creating and distributing rapid diagnostic tests and sample collection devices. Their products are widely adopted in various sectors, including clinical laboratories, hospitals, and community-based organizations, contributing to the detection and management of critical healthcare conditions.
Global Reach
OraSure's portfolio is not limited to a specific geographical area; rather, it enjoys global relevance. Their diagnostic tools are utilized across many clinical environments, public health initiatives, and even in direct-to-consumer markets. This breadth of coverage enhances their mission to promote health and wellbeing.
Connect with OraSure
Investors and media representatives can reach out to OraSure’s dedicated teams for inquiries. Jason Plagman leads the investor relations efforts for the company, while Amy Koch manages corporate communications.
Investors can contact Jason Plagman at investorinfo@orasure.com. Media inquiries are welcomed by Amy Koch at media@orasure.com.
Frequently Asked Questions
What is the purpose of the upcoming earnings call?
The earnings call aims to discuss the financial results for the fourth quarter of 2024 and address any relevant business developments.
How can I listen to the earnings call?
You can listen to the earnings call by accessing the webcast on OraSure’s investor relations webpage.
Will there be an opportunity to ask questions during the call?
Yes, participants can pre-register to ask questions during the conference call.
What types of products does OraSure offer?
OraSure offers rapid diagnostic tests and sample collection devices, focusing on enhancing access to healthcare services.
How can I contact OraSure for more information?
You can contact the investor relations team at investorinfo@orasure.com or the media team at media@orasure.com for any inquiries.
